Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain

NCT01875848 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

FED

Sponsor class

Stopped Data safety monitoring board recommended due to low recruitment yield.

Conditions

Pain

Interventions

DRUG: buprenorphine/naloxone
DRUG: opioid dose escalation

Sponsor

VA Office of Research and Development